Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11527 posts found.

Sanofi’s Plavix combination recommended for European approval

December 21, 2009 Research and Development, Sales and Marketing DuoPlavin, Plavix, Sanofi, cabazitaxel, eplivanserin, idrabiotaparinux

Sanofi-Aventis has received the backing of a key European regulatory committee for its cardiology treatment DuoPlavin, which combines its blockbuster …
News

Dr Michael Rosenblatt appointed chief medical officer Merck

December 21, 2009 Research and Development, Sales and Marketing Dr Michael Rosenblatt, Merck & Co, appointment, appointments, research and development, sales and marketing

Merck & Co. appoints Dr Michael Rosenblatt executive VP and chief medical officer. He will be the company’s primary voice …
Appointment

Boehringer’s ovarian cancer drug enters phase III

December 18, 2009 Research and Development, Sales and Marketing Boehringer, Cancer, ovarian

Boehringer Ingelheim has started a new phase III trial for its investigational cancer drug BIBF 1120. The LUME-Ovar-1 programme will …
News

NICE still saying ‘no’ to Roche’s RoActemra

December 17, 2009 Sales and Marketing NICE, RoActemra, Roche

Roche will have to present a stronger case for arthritis drug RoActemra in order to gain approval, according to NICE. …
News

GSK signs needle-free vaccine alliance

December 16, 2009 Research and Development, Sales and Marketing GlaxoSmithKline, Intercell, patch, vaccines

GlaxoSmithKline has signed a deal with Intercell to see whether any of its vaccines could be made available in patch …
News

Commission launches new wave of anti-trust raids

December 15, 2009 Sales and Marketing Europe, European Commission, Lundbeck, Teva, generics, kroes

The European Commission has launched a new series of raids on pharmaceutical companies as part of its crackdown on alleged …
News

The future is personalised

December 15, 2009 Research and Development, Sales and Marketing diagnostic, industry, nestle, personalised, pricewaterhousecoopers

A new report says the market for personalised medicine products is set to grow strongly over the next few years, …
News

AstraZeneca’s Chris Brinsmead and ex-health minister Lord Darzi appointed ambassadors for UK lifescience

December 15, 2009 Research and Development, Sales and Marketing AstraZeneca, Darzi, UK, appointment, research and development, sales and marketing

AstraZeneca UK’s chairman Chris Brinsmead and former health minister Lord Ara Darzi are among six newly appointed private sector business …
Appointment

MabThera shows improved leukaemia survival benefits

December 14, 2009 Sales and Marketing CLL, MabThera, Roche

MabThera/Rituxan is the first treatment to show improved survival in previously untreated patients with chronic lymphocytic leukaemia (CLL), according to …
News

Pfizer UK’s Theodora Anastasi joins The MSI Consultancy

December 14, 2009 Sales and Marketing MSI, appointment, sales and marketing

Pharmaceutical consultancy firm The MSI Consultancy has appointed Theodora Anastasi as a consultant.
Appointment

AZ licences late-stage depression candidate

December 8, 2009 Sales and Marketing AZ, Targacept, depression

AstraZeneca is to pay $200 million up front for rights to a late-stage developmental drug aimed at sufferers from depression …
News

BMS and Pfizer will file apixaban in Europe next year

December 8, 2009 Sales and Marketing BMS, Pfiizer, Pfizer, VTE, apixaban

Bristol-Myers Squibb and Pfizer are to submit their new anti-clotting drug for European approval in the first half of next …
News

Dr Yvonne Lamb to join Norgine as director of global pharmacovigilance

December 8, 2009 Research and Development, Sales and Marketing Norgine, appointment, research and development, sales and marketing

Norgine has appointed Dr Yvonne Lamb as director, global pharmacovigilance, with effect from January 25 2010. A qualified physician, Yvonne …
Appointment

Novartis’ COPD contender cleared in EU

December 4, 2009 Sales and Marketing COPD, Novartis, resp

 Novartis has been given a green light in the European Union to sell its Onbrez respiratory drug, allowing the firm …
News

Professor Chris Ham to lead The King’s Fund from April, 2010

December 3, 2009 Sales and Marketing UK, appointment, king's fund

Professor Chris Ham has been appointed new chief executive of UK health think tank The King’s Fund.Professor Ham, currently professor …
Appointment
The Gateway to Local Adoption Series

Latest content

Scots neonatal innovations target hearing loss and earlier care

August 28, 2026

FDA grants De Novo authorisation to light-filtering device for migraine

August 28, 2026

Southgate opens Innovation Lab for logistics and fulfilment development

August 27, 2026

Bioptimus partners with Cancer Research Horizons to expand AI cancer data set

August 27, 2026

Agentis Health Group acquires Clinical Pharmacist Solutions

August 26, 2026